Janine Jamieson
Janine Jamieson is European Editor for International Pharmaceutical Quality (IPQ) and previously a Pharmaceutical Assessor at the UK Medicines and Healthcare products Regulatory Agency (MHRA). Janine is co-chair of the TOPRA CMC SPIN committee and co-chair of the RI SPIN committee.
LinkedIn: https://www.linkedin.com/in/janine-jamieson-a4a82252/
JournalRegulatory reforms in China: Strengthening excipient quality and accession to PIC/S
This article explores new initiatives in China to strengthen the quality supervision of pharmaceutical excipients and pharmaceutical packaging materials.
Industry newsHarmonisation, fast track and reliance activities in focus at recent EDQM meetings
Leaders from the European Directorate for the Quality of Medicines & HealthCare (EDQM), which is home to the European Pharmacopoeia (PhEur), participated in two public outreach events in May 2026. The first was on pharmacopoeial harmonisation in collaboration with United States Pharmacopoeia (USP), and the second on fast track and ...
Industry newsSaudi FDA vision to be a leading regulator includes updating guidance on combination products
This industry news updates shares Saudi FDA’s updated guidance for combination products.
Journal2025 Regulatory Intelligence Conference Europe: Meeting report
This article summarises sessions from the TOPRA/RAPS 2025 Regulatory Intelligence Conference Europe.
JournalPS1: Tailored development of biosimilars without efficacy and safety studies – Is this the future?
This is a report of the PS1 session that took place at this year’s Symposium.
JournalICH Q1 guideline revisions to promote innovation and enable global patient access to high-quality medicines
This article looks at the new ICH Q1 stability guidance and its various approaches to help promote innovation.
Industry newsMHRA cross-agency team outlines emerging considerations for the manufacture of personalised medicines
This industry news update shares the MHRA’s guidance for the manufacture of personalised medicines.
Industry newsExtension to ICMRA post-approval change collaborative pilots
This industry news update looks at the collaborative pilots led by the ICMRA and other regulatory agencies.
Industry newsKey milestone reached in African medicines regulation
A key milestone for medicines regulation in Africa has been reached with the first continental listing of five medicinal products by the African Medicines Regulatory Harmonisation (AMRH) Steering Committee.
Meeting ReportMD5: Innovation in Drug-Device Combinations
The session was opened by Bjorg Hunter posing a question about how innovative companies can manage often complex and different global regulations when they are developing connected, environmentally friendly products for the benefit of the patients…
Meeting ReportIVD3: EU Implementation: Current State
The session was opened by Bjorg Hunter posing a question about how innovative companies can manage often complex and different global regulations when they are developing connected, environmentally friendly products for the benefit of the patients…